Microbial degradation of pharmaceuticals followed by a simple HPLC-DAD method

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 47, Issue 13, 2012, Pages 2151-2158

  Ribeiro, Ana R ^a,b,c   Gonçalves, Virgínia M F ^a   Maia, Alexandra S ^a   Carvalho, Maria F ^b   Castro, Paula M L ^b   Tiritan, Maria E ^a,c  

^a UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^b UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

activated sludge; biodegradation; carbamazepine; fluoroaromatic compounds; HPLC DAD; persistent pharmaceuticals

Indexed keywords

ACTIVATED SLUDGE; ANTI-INFLAMMATORIES; BACTERIAL CONSORTIUM; CARBAMAZEPINE; CIPROFLOXACIN; DICLOFENAC; DIODE ARRAY DETECTORS; ENVIRONMENTAL-FRIENDLY; FLUOROAROMATIC COMPOUNDS; HPLC-DAD; MICROBIAL CONSORTIA; MICROBIAL DEGRADATION; MOBILE PHASE; PHARMACEUTICAL INGREDIENTS; TARGET COMPOUND; THERAPEUTIC CLASS; TRIETHYLAMINES; TRIFLUOROACETIC ACIDS; TRIMETHOPRIM;

AMIDES; ANTIBIOTICS; ETHANOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROBIOLOGY; ORGANIC SOLVENTS;

BIODEGRADATION;

ALCOHOL; CARBAMAZEPINE; CHEMICALS AND DRUGS; CIPROFLOXACIN; DICLOFENAC; PHARMACEUTICAL INGREDIENT; SULFAMETHOXAZOLE; TRIETHYLAMINE; TRIFLUOROACETIC ACID; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACCURACY; ACTIVATED SLUDGE; ARTICLE; DIODE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY DIODE ARRAY DETECTOR; MICROBIAL CONSORTIUM; MICROBIAL DEGRADATION; PHYSICAL PHASE;

CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHYLAMINES; HYDROGEN-ION CONCENTRATION; SEWAGE; TRIFLUOROACETIC ACID;

BACTERIA (MICROORGANISMS);

EID: 84864851750     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934529.2012.696422     Document Type: Article

References (41)

1. K̈ummerer, K. Emerging contaminants. In Treatise on Water Science; Wilderer, P., Eds.; Elsevier: Oxford, 2011; 69-87.
2. Corcoran, J.; Winter, M.J.; Tyler, C.R. Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fish. Crit. Rev. Toxicol. 2010, 40(4), 287-304.
3. K̈ummerer, K. The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges. J. Environ. Manag. 2009, 90(8), 2354-2366.
4. Ternes, T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, 3245-3260. (Pubitemid 28473035)
5. Daneshvar, A.; Svanfelt, J.; Kronberg, L.; Pŕevost, M.; Weyhenmeyer, G.A. Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river-lake system.Chemosphere 2010, 80(3), 301-309.
6. Madureira, T.V.; Barreiro, J.C.; Rocha, M.J.; Rocha, E.; Cass, Q.B.; Tiritan, M.E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci. Total Environ. 2010, 408(22), 5513-5520.
7. Valćarcel, Y.; Alonso, S.G.; Rodŕ?guez-Gil, J.L.; Maroto, R.R.; Gil, A.; Cataĺa, M. Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in riverand drinking-water of the Madrid Region in Spain. Chemosphere 2011, 82(7), 1062-1071.
8. Vulliet, E.; Cren-Oliv́e, C. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ. Pollut. 2011, 159(10), 2929-2934.
9. Magńer, J.; Filipovic, M.; Alsberg, T. Application of a novel solidphase-extraction sampler and ultra-performance liquid chromatography quadrupole-time-of-flight mass spectrometry for determination of pharmaceutical residues in surface sea water. Chemosphere 2010, 80(11), 1255-1260.
10. Daughton, C.G. Pharmaceutical ingredients in drinking water: Overview of occurrence and significance of human exposure. In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations, Halden, R., Eds.; ACS Symposium Series 1048. American Chemical Society: Washington, DC, Chapter 2, 2010; 1048, 9-68.
11. Lin, A.Y.-C.; Tsai, Y.-T. Occurrence of pharmaceuticals in Taiwan's surface waters: Impact of waste streams from hospitals and pharmaceutical production facilities. Sci. Total Environ. 2009, 407(12), 3793-3802.
12. Larsson, D.G.J.; de Pedro, C.; Paxeus, N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148(3), 751-755. (Pubitemid 47334856)
13. Li, D.; Yang, M.; Hu, J.; Ren, L.; Zhang, Y.; Li, K. Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ. Toxicol. Chem. 2008, 27(1), 80-86.
14. Li, D.; Yang, M.; Hu, J.; Zhang, Y.; Chang, H.; Jin, F. Determination of penicillin G and its degradation products in a penicillin production wastewater treatment plant and the receiving river.Water Res. 2008, 42(1-2), 307-317. (Pubitemid 350296234)
15. Tambosi, J.L.; deSena, R.F.; Favier, M.; Gebhardt, W.; Jośe, H.J.; Schr̈oder, H.F.; Moreira, R.d.F.P.M. Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes. Desalination 2010, 261(1-2), 148-156.
16. Bernhard, M.; M̈uller, J.; Knepper, T.P. Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimised lab-scalemembrane bioreactor and activated sludge treatment.Water Res. 2006, 40(18), 3419-3428. (Pubitemid 44436443)
17. Ribeiro, A.R.; Carvalho, M.F.; Afonso, C.M.M.; Tiritan, M.E.; Castro, P.M.L. Microbial degradation of 17?-estradiol and 17?-ethinylestradiol followed by a validated HPLC-DAD method. J. Environ. Sci. Health Pt. B 2010, 45(4), 265-273.
18. Sim,W.-J.; Lee, J.-W.; Oh, J.-E. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 2010, 158(5), 1938-1947.
19. Interactive PhysProp Database. 2011. Available at http://www.syrres.com/ what-we-do/databaseforms.aspx?id=386.
20. Yoon, Y.; Ryu, J.; Oh, J.; Choi, B.-G.; Snyder, S.A. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 2010, 408(3), 636-643.
21. Carvalho, M.F.; Alves, C.C.T.; Ferreira, M.I.M.; De Marco, P.; Castro, P.M.L. Isolation and initial characterization of a bacterial consortium able to mineralize fluorobenzene. Appl. Environ. Microbiol. 2002, 68(1), 102-105. (Pubitemid 34031169)
22. Zhang, Y.; Geißen, S.-U.; Gal, C. Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73(8), 1151-1161.
23. Tauxe-Wuersch, A.; De Alencastro, L.F.; Grandjean, D.; Tarradellas, J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 2005, 39(9), 1761-1772. (Pubitemid 40719682)
24. Sui,Q.; Huang, J.; Deng, S.;Yu,G.;Fan,Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010, 44(2), 417-426.
25. Kumar, A.; Xagoraraki, I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system. Sci. Total Environ. 2010, 408(23), 5972-5989.
26. Ḧaggblom, M.M.; Bossert, I.D. Halogenated Organic Compounds-A Global Perspective. In Dehalogenation; Ḧaggblom, M.M.; Bossert, I.D., Eds.; Springer, New York, 2004; 3-29.
27. European Commission. Directive of the European Parliament and of theCouncil amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. Brussels: European Commission; 2012. p 35.
28. International Conference on Harmonization. Validation of Analytical procedures, 1996. Available at http://private. ich.org/LOB/media/MEDIA417.pdf (accessed March 2011).
29. US FDA. Bioanalytical Method Validation. Guidance for Industry; 2001. Available at http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM134409.pdf (accessed June 2011).
30. Welch, C.J.; Wu, N.; Biba, M.; Hartman, R.; Brkovic, T.; Gong, X.; Helmy, R.; Schafer, W.; Cuff, J.; Pirzada, Z.; Zhou, L. Greening analytical chromatography. Trends Anal. Chem. 2010, 29(7), 667-680.
31. Ingerslev, F.; Halling-Sørensen, B. Biodegradability properties of sulfonamides in activated sludge. Environ. Toxicol. Chem. 2000, 19(10), 2467-2473.
32. Le-Minh, N.; Khan, S.J.; Drewes, J.E.; Stuetz, R.M. Fate of antibiotics during municipal water recycling treatment processes. Water Res. 2010, 44(15), 4295-4323.
33. Radjenovic, J.; Petrovic, M.; Barcel ́ o, D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43(3), 831-841.
34. Kasprzyk-Hordern, B.; Dinsdale, R.M.; Guwy, A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43(2), 363-380.
35. Sipma, J.; Osuna, B.; Collado,N.;Moncĺ us,H.; Ferrero,G.;Comas, J.; Rodriguez-Roda, I. Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 2010, 250(2), 653-659.
36. Rosal, R.; Rodŕ?guez, A.; Perdiǵon-Meĺon, J.A.; Petre, A.; Garć?a-Calvo, E.; Ǵomez, M.J.; Ag̈uera, A.; Ferńandez-Alba, A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 2010, 44(2), 578-588.
37. Suarez, S.; Lema, J.M.; Omil, F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010, 44(10), 3214-3224.
38. Drillia, P.; Dokianakis, S.N.; Fountoulakis, M.S.; Kornaros, M.; Stamatelatou, K.; Lyberatos, G. On the occasional biodegradation of pharmaceuticals in the activated sludge process: The example of the antibiotic sulfamethoxazole. J. Hazard. Mater. 2005, 122(3), 259-265. (Pubitemid 40828492)
39. Key, B.D.; Howell, R.D.; Criddle, C.S. Fluorinated Organics in the Biosphere. Environ. Sci. Technol. 1997, 31(9), 2445-2454. (Pubitemid 27382363)
40. Ḧaggblom, M.M. Microbial breakdown of halogenated aromatic pesticides and related compounds. FEMS Microbiol. Lett. 1992, 103(1), 29-71.
41. Yu, J.T.; Bouwer, E.J.; Coelhan, M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric. Water Manag. 2006, 86(1-2), 72-80. (Pubitemid 44693032)